These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 19966185
1. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior. Tang JZ, Zuo ZH, Kong XJ, Steiner M, Yin Z, Perry JK, Zhu T, Liu DX, Lobie PE. Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185 [Abstract] [Full Text] [Related]
2. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Tran TH, Utama FE, Lin J, Yang N, Sjolund AB, Ryder A, Johnson KJ, Neilson LM, Liu C, Brill KL, Rosenberg AL, Witkiewicz AK, Rui H. Cancer Res; 2010 Feb 15; 70(4):1711-21. PubMed ID: 20124477 [Abstract] [Full Text] [Related]
3. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species. Du W, Wang YC, Hong J, Su WY, Lin YW, Lu R, Xiong H, Fang JY. J Cell Physiol; 2012 Jun 15; 227(6):2421-9. PubMed ID: 21826656 [Abstract] [Full Text] [Related]
4. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a. Yip SH, Eguchi R, Grattan DR, Bunn SJ. J Neuroendocrinol; 2012 Dec 15; 24(12):1484-91. PubMed ID: 22775396 [Abstract] [Full Text] [Related]
5. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells. Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX. Int J Oncol; 2012 Dec 15; 41(6):2285-95. PubMed ID: 23064471 [Abstract] [Full Text] [Related]
8. Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells. Liang QC, Xiong H, Zhao ZW, Jia D, Li WX, Qin HZ, Deng JP, Gao L, Zhang H, Gao GD. Cancer Lett; 2009 Jan 08; 273(1):164-71. PubMed ID: 18793823 [Abstract] [Full Text] [Related]
9. Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells. Casetti L, Martin-Lannerée S, Najjar I, Plo I, Augé S, Roy L, Chomel JC, Lauret E, Turhan AG, Dusanter-Fourt I. Cancer Res; 2013 Apr 01; 73(7):2052-8. PubMed ID: 23400594 [Abstract] [Full Text] [Related]
10. Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis. Kaymaz BT, Selvi N, Gündüz C, Aktan C, Dalmızrak A, Saydam G, Kosova B. Ann Hematol; 2013 Jan 01; 92(2):151-62. PubMed ID: 23053176 [Abstract] [Full Text] [Related]
12. A novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration. Bernaciak TM, Zareno J, Parsons JT, Silva CM. Breast Cancer Res; 2009 Jan 01; 11(4):R52. PubMed ID: 19630967 [Abstract] [Full Text] [Related]
13. PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells. Vidal LJ, Perry JK, Vouyovitch CM, Pandey V, Brunet-Dunand SE, Mertani HC, Liu DX, Lobie PE. Mol Cancer Res; 2010 Mar 01; 8(3):444-56. PubMed ID: 20197384 [Abstract] [Full Text] [Related]
14. Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT. Clin Cancer Res; 2008 Mar 01; 14(5):1317-24. PubMed ID: 18316550 [Abstract] [Full Text] [Related]
15. STAT5A and STAT5B have opposite correlations with drug response gene expression. Lamba V, Jia B, Liang F. Biochem Biophys Res Commun; 2016 Oct 14; 479(2):117-124. PubMed ID: 27264955 [Abstract] [Full Text] [Related]
16. CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity. Peng B, Sutherland KD, Sum EY, Olayioye M, Wittlin S, Tang TK, Lindeman GJ, Visvader JE. Mol Endocrinol; 2002 Sep 14; 16(9):2019-33. PubMed ID: 12198240 [Abstract] [Full Text] [Related]
17. Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia. Kollmann S, Grundschober E, Maurer B, Warsch W, Grausenburger R, Edlinger L, Huuhtanen J, Lagger S, Hennighausen L, Valent P, Decker T, Strobl B, Mueller M, Mustjoki S, Hoelbl-Kovacic A, Sexl V. Leukemia; 2019 Jul 14; 33(7):1583-1597. PubMed ID: 30679796 [Abstract] [Full Text] [Related]
18. Identification of STAT5A and STAT5B target genes in human T cells. Kanai T, Seki S, Jenks JA, Kohli A, Kawli T, Martin DP, Snyder M, Bacchetta R, Nadeau KC. PLoS One; 2014 Jul 14; 9(1):e86790. PubMed ID: 24497979 [Abstract] [Full Text] [Related]
19. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Liu X, Robinson GW, Hennighausen L. Mol Endocrinol; 1996 Dec 14; 10(12):1496-506. PubMed ID: 8961260 [Abstract] [Full Text] [Related]
20. Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. Jenks JA, Seki S, Kanai T, Huang J, Morgan AA, Scalco RC, Nath R, Bucayu R, Wit JM, Al-Herz W, Ramadan D, Jorge AA, Bacchetta R, Hwa V, Rosenfeld R, Nadeau KC. Clin Immunol; 2013 Aug 14; 148(2):227-36. PubMed ID: 23773921 [Abstract] [Full Text] [Related] Page: [Next] [New Search]